Spinogenix Founder and CEO Stella Sarraf sits with ForbesWomen Editor Maggie McGrath at the Nasdaq MarketSite to discuss her company's novel approach to treating neurodegenerative disease at the synaptic level.
00:00 – Intro: Meet Stella Rouseff, Founder of SpinoGenics
00:49 – Can Synapse Drugs Help Restore Memory?
02:01 – What Synaptic Regeneration Actually Looks Like
03:00 – Why SpinoGenics Took a Different Scientific Path
04:29 – Where the Trials Stand Today
06:43 – U.S.
21 min
2025